晚讯|AI+生物制造风口!9个涉及蛋白质设计案例获国家级认可!FDA获批、国产核药创“全球首个”,能否趁势崛起?

生物谷
Jul 11

1. AI+生物制造风口!9个涉及蛋白质设计案例获国家级认可!近日,工业和信息化部发布《人工智能在生物制造领域典型应用案例名单(第一批)公示》。本次案例共涉及15家企业和1家科研院所,包含北京昭衍生物、北京诚益通、上海天鹜科技、迪必尔、安徽元构生物、百图生科、中国科学院天津工业生物技术研究所、上海智峪生物等,均是生物制造领域较为知名的企业院所。16个案例中9个涉及高性能蛋白质元件设计及构建,显示...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10